These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
79 related items for PubMed ID: 2577961
21. Role of transforming growth factor beta in diabetic nephropathy. Ziyadeh FN. Exp Nephrol; 1994; 2(2):137. PubMed ID: 8082013 [No Abstract] [Full Text] [Related]
22. Controversies on the prevention of diabetic nephropathy. Chiarelli F, Verrotti A, Basciani F, di Ricco L, Sabatino G, Morgese G. J Pediatr Endocrinol Metab; 1998 Apr; 11 Suppl 2():365-9. PubMed ID: 9642666 [Abstract] [Full Text] [Related]
23. Influence of C-peptide on early glomerular changes in diabetic mice. Maezawa Y, Yokote K, Sonezaki K, Fujimoto M, Kobayashi K, Kawamura H, Tokuyama T, Takemoto M, Ueda S, Kuwaki T, Mori S, Wahren J, Saito Y. Diabetes Metab Res Rev; 2006 Apr; 22(4):313-22. PubMed ID: 16389646 [Abstract] [Full Text] [Related]
24. Dietary protein and the progression of renal disease. Meyer TW, Lawrence WE, Brenner BM. Kidney Int Suppl; 1983 Dec; 16():S243-7. PubMed ID: 6588259 [No Abstract] [Full Text] [Related]
25. Anionic charge sites in the kidney: comparison of two diabetic rat models. Ward-Cook KM, Mahan JD, Frenchko CE, Albright A, Chiasera JM, McAllister C. Ann Clin Lab Sci; 1999 Dec; 29(4):286-98. PubMed ID: 10528828 [Abstract] [Full Text] [Related]
26. Glomerular dysfunction in diabetic nephropathy. Zucchelli P, Zuccalà A, Sturani A. Postgrad Med J; 1988 Dec; 64 Suppl 3():22-30; discussion 48-9. PubMed ID: 3074295 [Abstract] [Full Text] [Related]
27. Can rodent models of diabetic kidney disease clarify the significance of early hyperfiltration?: recognizing clinical and experimental uncertainties. Levine DZ. Clin Sci (Lond); 2008 Jan; 114(2):109-18. PubMed ID: 18062776 [Abstract] [Full Text] [Related]
28. The glomerular hyperfiltration of diabetes is not associated with elevated plasma levels of glucagon and growth hormone. Wiseman MJ, Redmond S, House F, Keen H, Viberti GC. Diabetologia; 1985 Oct; 28(10):718-21. PubMed ID: 4065449 [Abstract] [Full Text] [Related]
31. Diabetic glomerulopathy: a dynamic process produced by the diabetic environment. Steffes MW, Brown DM, Mauer SM. Adv Exp Med Biol; 1979 Nov; 124():157-66. PubMed ID: 116484 [No Abstract] [Full Text] [Related]
33. Diabetic nephropathy: can the natural history be modified? Narins RG. Am J Med; 1991 Feb 21; 90(2A):70S-75S. PubMed ID: 1994723 [Abstract] [Full Text] [Related]
34. Heparan sulphate in the pathogenesis of diabetic nephropathy. Kofoed-Enevoldsen A. Diabetes Metab Rev; 1995 Jul 21; 11(2):137-60. PubMed ID: 7555565 [No Abstract] [Full Text] [Related]
35. C-Peptide effects on renal physiology and diabetes. Rebsomen L, Khammar A, Raccah D, Tsimaratos M. Exp Diabetes Res; 2008 Jul 21; 2008():281536. PubMed ID: 18509500 [Abstract] [Full Text] [Related]
37. [Pathogenesis of diabetic microangiopathy. I. Isolation of kidney glomeruli and glomerular basal membranes. Performance and principle of method]. Wahl P, Krezdorn W, Deppermann D. Klin Wochenschr; 1970 Jun 01; 48(11):650-3. PubMed ID: 4931328 [No Abstract] [Full Text] [Related]
38. Glomerular hyperfiltration after protein ingestion, during glucagon infusion, and in insulin-dependent diabetes is induced by a liver hormone: deficient production of this hormone in hepatic failure causes hepatorenal syndrome. Alvestrand A, Bergström J. Lancet; 1984 Jan 28; 1(8370):195-7. PubMed ID: 6141338 [Abstract] [Full Text] [Related]